-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

New Insights Into Germline Predisposition

PhD Trainee
Program: Scientific Workshops @ ASH
Friday, December 4, 2020: 9:05 AM-9:52 AM
Moderators:
Disclosures:
No relevant conflicts of interest to declare.

Mike Walsh, MD

Memorial Sloan Kettering Cancer Center, New York, NY

Mike Walsh, MD

Memorial Sloan Kettering Cancer Center, New York, NY

David Wu, MD, PhD

University of Washington, Seattle, WA

David Wu, MD, PhD

University of Washington, Seattle, WA

Claire C Homan, PhD

Centre for Cancer Biology, University of South Australia, Adelaide, SA, Australia

Claire Homan

The University of South Australia, Adelaide, Australia

Henik Hasle, MD

Aarhus University Hospital, Aarhus, Denmark

Lisa J. McReynolds, MD, PhD

NCI, National Institutes of Health, Bethesda, MD; Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Bethesda, MD

Lisa J. McReynolds, MD, PhD

NCI, National Institutes of Health, Bethesda, MD

Marja Hakkarainen, MD

Helsinki University Hospital Comprehensive Cancer Center, The University of Helsinki, Helsinki, Finland

Marja Hakkarainen, MD

Helsinki University Hospital Comprehensive Cancer Center, The University of Helsinki, Helsinki, Finland